MED-RX Wound Care Kit Recalled by CHS Over Sterility Breach Risk 2026

Canadian Hospital Specialties Ltd. (CHS) has issued a recall of its MED-RX Wound Care Kit following notification from BD Canada of a potential sterility breach in the BD Chloraprep™ Clear applicators used in the product. The recall, classified as Type II by Health Canada, affects multiple lot numbers under catalogue models 85-2821 and 85-4149, and was initiated on June 10, 2026. Healthcare providers and patients who have received or used these kits should take immediate action.

What Products Are Being Recalled?

The affected product is the MED-RX Wound Care Kit, manufactured by Canadian Hospital Specialties Ltd. (doing business as CHS), located at 2760 Brighton Road, Oakville, Ontario. The kits are identified under catalogue numbers 85-2821 and 85-4149, and the following lot numbers are affected:

• Lot 204012
• Lot 195425
• Lot 193719
• Lot 193717
• Lot 202405
• Lot 204015
• Lot 204013
• Lot 203054
• Lot 202333

These lot numbers apply to both catalogue models included in the recall.

Why Was This Recall Issued?

The recall was triggered after BD Canada notified CHS that specific lots of the BD Chloraprep™ Clear – 1 ml and Clear 1.5 ml applicators are being recalled due to a potential breach of sterility. The sterility issue arises from wrinkles in the paper lidding of the packaging, which may extend to the seal area, compromising the sterile barrier. CHS incorporates these Chloraprep applicators into the MED-RX Wound Care Kits that it manufactures, making the end product potentially non-sterile and unsafe for use on patients.

Who Is Affected?

This recall affects both the general public and healthcare professionals who may have received, dispensed, or used MED-RX Wound Care Kits from the identified lot numbers. Wound care kits are typically used in clinical and home-care settings for cleaning and preparing wounds prior to treatment. Patients who have had these kits applied to open wounds or surgical sites may be at risk if the sterility of the applicator was compromised.

What Should You Do?

• Check all MED-RX Wound Care Kits currently in your possession for the affected lot numbers (204012, 195425, 193719, 193717, 202405, 204015, 204013, 203054, 202333) and catalogue numbers 85-2821 or 85-4149.
• Stop using any kits from the affected lots immediately.
• Contact Canadian Hospital Specialties Ltd. (CHS) directly for further instructions, return procedures, or replacement arrangements.
• Healthcare facilities should remove affected stock from inventory and quarantine it pending return or disposal guidance from CHS.
• If a non-sterile applicator has already been used on a patient, consult with a healthcare professional regarding any necessary follow-up or monitoring for signs of infection.
• You may also contact Health Canada for additional information or to report an adverse event related to this product.

Official Statement

According to Health Canada, CHS was notified by BD Canada that they are conducting a recall of specific lots of the BD Chloraprep™ Clear – 1 ml and Clear 1.5 ml applicators. The applicators with paper lidding are being recalled due to a potential breach of sterility in the packaging caused by wrinkles in the paper lidding, which may extend to the seal area. CHS Ltd uses these Chloraprep applicators in the medical devices they manufacture. Health Canada has classified this recall as Type II, indicating that use of the product may cause temporary adverse health consequences, or where the probability of serious adverse health consequences is remote. The identification number for this recall is RA-82219.